The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Prof. Anas Younes | ASH 2017 | Addition of BV (Echelon-1 study) in the practice of treating advanced HL

Featured
Dec 12, 2017
Share:

59th ASH Annual Meeting and Exposition, 9 - 12 Dec 2017, Atlanta, GA
Professor Anas Younes
Memorial Sloan Kettering Cancer Center, New York, US

Interview topic: How will the addition of BV (from the Phase 3 Echelon-1 study) change the practice of treating advanced stage HL?

Prof. Anas Younes | ASH 2017 | Addition of BV (Echelon-1 study) in the practice of treating advanced HL

Share: